-
公开(公告)号：US09540323B2
公开(公告)日：2017-01-10
申请号：US14418023
申请日：2013-07-30
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Alexandre L'Heureux , Sheldon Hiebert , Carol Hu , Patrick Y. S. Lam , John Lloyd , Zulan Pi , Jennifer X. Qiao , Carl Thibeault , George O. Tora , Wu Yang , Yufeng Wang , Tammy C. Wang , Michael S. Bowsher , Ruel Rejean
IPC: C07D209/26 , C07D401/04 , C07D401/12 , C07D403/04 , C07D403/14 , C07D409/04 , C07D413/04 , C07D417/12 , C07D417/14 , C07D471/04 , C07D498/04 , C07D209/14 , C07D513/04 , C07D403/12 , C07D413/14 , C07D417/04
CPC classification number: C07D209/26 , C07D209/14 , C07D401/04 , C07D401/12 , C07D403/04 , C07D403/12 , C07D403/14 , C07D409/04 , C07D413/04 , C07D413/14 , C07D417/04 , C07D417/12 , C07D417/14 , C07D471/04 , C07D498/04 , C07D513/04
Abstract: The present invention provides compounds of Formula (I): Formula (I) as defined in the specification and compositions comprising any of such novel compounds. These compounds are antagonists of P2Y1 receptor which may be used medicaments.
Abstract translation: 本发明提供式（I）化合物：如说明书中所定义的式（I）和包含任何这些新化合物的组合物。 这些化合物是可以使用药物的P2Y1受体的拮抗剂。
-
Patent Agency Ranking
2.发明申请AMINO-HETEROARYL 7-HYDROXY-SPIROPIPERIDINE INDOLINYL ANTAGONISTS OF P2Y1 RECEPTOR 有权P2Y1受体的氨基 - 异羟肟酸7-羟基 - 螺吡啶吲哚宁拮抗剂公开(公告)号：US20150197521A1
公开(公告)日：2015-07-16
申请号：US14417985
申请日：2013-07-29
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Jennifer X. Qiao , Carol Hui Hu , Carl Thibeault
IPC: C07D471/10 , C07D519/00
CPC classification number: C07D471/10 , C07D519/00
Abstract: The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are antagonists of P2Y1 receptor which may be used as medicaments.
Abstract translation: 本发明提供式（I）化合物：如说明书中所定义和包含任何这些新化合物的组合物。 这些化合物是可用作药物的P2Y1受体的拮抗剂。
-
公开(公告)号：US09428504B2
公开(公告)日：2016-08-30
申请号：US14418011
申请日：2013-07-30
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Carl Thibeault , Charles G. Clark , Indawati DeLucca , Carol Hui Hu , Yoon Jeon , Patrick Y. S. Lam , Jennifer X. Qiao , Wu Yang , Yufeng Wang , Tammy C. Wang
IPC: C07D471/10 , C07D519/00
CPC classification number: C07D471/10 , C07D519/00
Abstract: The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are antagonists of P2Y1 receptor and may be used as medicaments in the treatment and/or prophylaxis of thromboembolic disorders.
-
4.发明授权Amino-heteroaryl 7-hydroxy-spiropiperidine indolinyl antagonists of P2Y1 receptor 有权P2Y1受体的氨基 - 杂芳基7-羟基 - 螺哌啶二氢吲哚基拮抗剂公开(公告)号：US09120798B2
公开(公告)日：2015-09-01
申请号：US14417985
申请日：2013-07-29
Applicant: Bristol-Myers Squibb Company
Inventor： Jennifer X. Qiao , Carol Hui Hu , Carl Thibeault
IPC: C07D471/10 , C07D519/00
CPC classification number: C07D471/10 , C07D519/00
Abstract: The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are antagonists of P2Y1 receptor which may be used as medicaments.
Abstract translation: 本发明提供式（I）化合物：如说明书中所定义和包含任何这些新化合物的组合物。 这些化合物是可用作药物的P2Y1受体的拮抗剂。
-
公开(公告)号：US20150259286A1
公开(公告)日：2015-09-17
申请号：US14418023
申请日：2013-07-30
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Alexandre L'Heureux , Sheldon Hiebert , Carol Hu , Patrick Y.S. Lam , John Lloyd , Zulan Pi , Jennifer X. Qiao , Carl Thibeault , George O. Tora , Wu Yang , Yufeng Wang , Tammy C. Wang , Michael S. Bowsher , Ruel Rejean
IPC: C07D209/26 , C07D401/12 , C07D403/12 , C07D513/04 , C07D413/04 , C07D401/04 , C07D403/04 , C07D498/04 , C07D417/14 , C07D413/14 , C07D409/04 , C07D417/12 , C07D417/04
CPC classification number: C07D209/26 , C07D209/14 , C07D401/04 , C07D401/12 , C07D403/04 , C07D403/12 , C07D403/14 , C07D409/04 , C07D413/04 , C07D413/14 , C07D417/04 , C07D417/12 , C07D417/14 , C07D471/04 , C07D498/04 , C07D513/04
Abstract: The present invention provides compounds of Formula (I): Formula (I) as defined in the specification and compositions comprising any of such novel compounds. These compounds are antagonists of P2Y1 receptor which may be used medicaments.
Abstract translation: 本发明提供式（I）化合物：如说明书中所定义的式（I）和包含任何这些新化合物的组合物。 这些化合物是可以使用药物的P2Y1受体的拮抗剂。
-
6.发明申请公开(公告)号：US20150166538A1
公开(公告)日：2015-06-18
申请号：US14418011
申请日：2013-07-30
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor： Carl Thibeault , Charles G. Clark , Indawati DeLucca , Carol Hui Hu , Yoon Jeon , Patrick Y.S. Lam , Jennifer X. Qiao , Wu Yang , Yufeng Wang , Tammy C. Wang
IPC: C07D471/10 , C07D519/00
CPC classification number: C07D471/10 , C07D519/00
Abstract: The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are antagonists of P2Y1 receptor and may be used as medicaments in the treatment and/or prophylaxis of thromboembolic disorders.
Abstract translation: 本发明提供式（I）化合物：如说明书中所定义和包含任何这些新化合物的组合物。 这些化合物是P2Y1受体的拮抗剂，可用作治疗和/或预防血栓栓塞障碍的药物。
-
-
-
-
-
Search Results
6
records
(took 0.021 seconds)
